Clinical Neuroscience & AI

Artificial intelligence and brain-computer interfaces are moving from prototype to clinic. GCNN 2027 will showcase Neuralink and Synchron BCI early-feasibility outcomes for paralysis and ALS communication, speech-decoding cortical implants, and the regulatory pathway emerging at the FDA. AI-augmented imaging — large vessel occlusion triage (Viz.ai, RapidAI), automated MS lesion segmentation, hippocampal volumetry for AD, and foundation models for radiology — will be examined alongside seizure-forecasting wearables, smartphone-based cognitive and motor digital biomarkers, and the data, privacy and equity questions raised by ambient AI in the neurology clinic.